CRVS earnings: a positive outcome, +6.8%

+6.8%Corvus Pharmaceuticals, Inc. (CRVS) →

On November 7, 2023, Corvus Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.8% in the window around the event. It had already run -8.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$1.48

1d before

$1.58

Event day

$1.60

1d after

$1.39

5d after

Pre-catalyst setup

-8.1%

30-day run-up

7563%

30-day volatility

2.2×

volume spike

CRVS catalyst calendar More earningss Prediction track record Full catalyst calendar